Latest Governance News

Big River Industries reported a 3.3% revenue decline and a 26% drop in EBITDA for 1H FY25, reflecting ongoing residential market challenges. Despite this, the company is investing in growth and operational efficiencies, maintaining a cautiously optimistic outlook for FY26 and beyond.

Big River Industries reports a 3.3% revenue decline in 1H FY25 but shows signs of operational resilience and strategic progress amid challenging market conditions.

Big River Industries reported a significant $17 million loss for the half-year ending December 2024, driven by a $20 million non-cash impairment charge and a 3.3% revenue decline. The company also announced a reduced fully franked interim dividend of 2 cents per share.

SRG Global has reported a record first half for FY25, posting a 21% revenue increase and upgrading its full-year profit guidance, driven by strong cash flow and successful integration of the Diona acquisition.

SRG Global has delivered a record first half in FY25, posting strong revenue and profit growth alongside a successful acquisition integration that boosts its water security and energy transition capabilities.

Infratil has increased its investment in CDC Data Centres by acquiring an additional 1.58% stake for approximately A$216 million, reinforcing its commitment to the fast-growing digital infrastructure sector.

Reliance Worldwide Corporation Limited has announced an ordinary dividend of USD 0.025 per share for the six months ending December 31, 2024, payable in April 2025. The dividend is unfranked and will be paid in Australian dollars based on a recent exchange rate.

Cardiex Limited has confirmed to the ASX that it holds no undisclosed information explaining the recent spike in its share price, affirming full compliance with continuous disclosure rules.

Morphic Ethical Equities Fund Limited reported a robust turnaround with a $2.96 million profit after tax for the half-year ended December 2024, reversing last year’s losses despite no dividends declared.

Superior Resources Limited issues a clarification on its Halls Reward Cu-Au-Ag Mine announcement, addressing compliance gaps while underscoring promising high-grade copper, gold, and silver targets revealed through historical data and ongoing exploration.

Neurizon Therapeutics reported a sharp rise in half-year losses to $7.28 million but marked significant progress with its lead drug NUZ-001 entering a major ALS clinical trial and securing critical regulatory designations.

VanEck Investments Limited has released its indicative dividends calendar for 2025, outlining expected dividend timings for over 50 exchange-traded funds (ETFs). This comprehensive schedule offers investors clarity on dividend announcements, ex-dates, and payment dates across a diverse range of funds.